Designer dogs: What is a breed anyway?
There's designer clothes, but they have nothing on designer dogs!
They come in a huge range of shapes and colours and sizes, from the tiny Chihuahua to the Great Dane.
In the animal world this much variation usually means different species, but not for dogs — so where did they all come from?
And what role did Victorian-era rats play in the development of 'breed standards'?
Featuring:
Joyce Sullivan, papillon breeder
Joyce Sullivan, papillon breeder Wayne Douglas OAM, Afghan Hound breeder
Wayne Douglas OAM, Afghan Hound breeder Esther Joseph, all breeds judge
Esther Joseph, all breeds judge Michael Worboys emeritus professor the University of Manchester
Michael Worboys emeritus professor the University of Manchester Professor Greger Larson, evolutionary genomics at the University of Oxford
Professor Greger Larson, evolutionary genomics at the University of Oxford Dr Angela Perri, zooarchaeologist, Chronicle Heritage
Dr Angela Perri, zooarchaeologist, Chronicle Heritage Dr. Elaine Ostrander, geneticist at National Institutes of Health (US)
Dr. Elaine Ostrander, geneticist at National Institutes of Health (US)
Dr Heidi Parker, geneticist at National Institutes of Health (US)
Further reading:
Production:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
4 days ago
- News.com.au
‘Over' versus ‘under' toilet paper debate finally settled
The position of a toilet paper roll may seem innocuous, but TP trustees have long been embroiled in a heated debate over the proper angle of the next square. There are two types of people in the world: The 'over' devotees who hang the roll so the on-deck wipe is facing the user, and the 'under' fans who position it so it's closer to the wall. Thankfully, a professional has finally closed the book on the matter — a whopping 250 years since the hygiene tool's invention. Primrose Freestone, professor of clinical microbiology at the UK's University of Leicester, says the somewhat counterintuitive 'under' position is more hygienic and effective — despite the original 1800s patent showing the roll in the more natural-seeming 'over' orientation, the Daily Mail reported. 'For the under position, there is less likely to be whole roll contamination,' Freestone argued. That's because 'handling of the toilet roll from the over position' requires the user to employ two hands to extract a square after doing one's business, per the microbiologist. One hand is used to hold the roll in place so it doesn't keep spinning forward and depositing too much paper, while the other takes the next segment. On the other hand, the 'under' method allows bathroom users to 'pin the sheets against the toilet wall' and tear them off with the same mitt without 'having to touch the exterior of the roll,' Freestone said. By only using one hand to harvest a square, the odds of transferring hand bacteria to the toilet tissue and perhaps vice versa are reduced. Meanwhile, using two hands increases the chances of spreading germs from one hand to the other. 'If someone who has wiped, say, once and the faecal matter has soaked through the layers of toilet paper and makes hand contact, the presumably right hand that did the wiping will likely be contaminated,' explained Freestone. 'Then that right hand may contaminate anything it touches as the toilet user reaches for more toilet paper, which they then fold for wipe two, possibly touching the left hand as it does so.' This is especially important given that both hands have, by the time we've sat down on the toilet, likely touched multiple microbe-laden surfaces from the doorknob to the toilet seat and lid. Even seemingly harmless items like bath mats are dirtier than toilet seats, research suggests. Freestone said public rest rooms are of particular concern due to excrement potentially contaminating the toilet door, stall, seat and other areas. Women, meanwhile, are the most at risk of getting infected via accidentally transferring microbes from the groin to the genitalia. On average, they also use more paper for both peeing and pooping. Interestingly, Freestone's theory is not shared by everyone. Dr Christian Moro, an associate professor of health sciences and medicine at Bond University in Australia, claimed that the 'under' method is the 'hanging' offence as it ups the likelihood that the toilet user will 'touch the wall behind when fishing for paper, leaving germs behind on that surface which can be spread to the next user.' Coincidentally, studies show that 70 per cent of people still prefer it compared to 30 per cent in favour of the 'under.'
ABC News
6 days ago
- ABC News
Regulators assessing bid to grow and sell genetically modified purple tomato in Australia
A genetically modified tomato the colour of an eggplant could be available on supermarket shelves as early as next year if regulators approved a bid to grow it in Australia. The purple tomato, as it is named, has been genetically modified to include genes from the edible snapdragon flower. Nathan Pumplin is the chief executive of Norfolk Healthy Produce, a United States-based company marketing the plant. He said the tomato had two snapdragon genes added, allowing it to make a class of antioxidants called anthocyanins, whose nutrients created the purple colour and were also associated with health benefits. "They're what make blueberries coloured, blackberries, eggplant skins, purple potatoes," Dr Pumplin said. The plant was developed by Cathie Martin at the John Innes Centre, an independent laboratory in the United Kingdom. She co-founded Norfolk Plant Sciences, a company aimed at transferring the fruits of the research to people's plates. Dr Pumplin said Professor Martin was a global leader in the study of how fruit and vegetables delivered nutrients to consumers. Professor Martin previously received the Rank Prize for Nutrition – one of the field's most prestigious awards – for her work. "She's also a type 1 diabetic, so her whole scientific career she's focused on ways to make the foods that we eat healthier and more nutritious," Dr Pumplin said. After 18 years of development the product was approved to be grown and sold in the US and has been on the market there for two years. Dr Pumplin said last year the company sold more than 100,000 punnets of the fruit at grocery stores and 13,000 packets of seeds to home gardeners. The team is now taking the plant worldwide and is focusing on the Australian and Canadian markets. All Aussie Farmers, a Victoria-based fresh produce marketing company, has entered an exclusive commercial partnership to bring the fruit here. Managing director Travis Murphy said there had already been plenty of interest. "Food service guys are wanting to know when they can get it for their chefs and our retail guys are asking when they can have it to put into their retail shops," he said. Australia has strict regulations on growing genetically modified crops and to date only canola, cotton, safflower, bananas and flowers have been approved. The Office of the Gene Technology Regulator (OGTR) is the government oversight body and crops will only be approved if they are proven to be safe for people and the environment. A spokesperson said a risk assessment of the purple tomato would be undertaken, which would lead to the development of a risk management plan to allow the plant to be grown and sold domestically. Public consultation will begin in September. "Written comments will be sought and the consultation will be open for at least 30 days," the OTGR spokesperson said. "Anyone can register to receive notifications on the OGTR website." All genetically modified foods for sale and consumption must also undergo a safety assessment by Food Standards Australia New Zealand. Mr Murphy said the purple tomato would first be grown in greenhouses in south-east Queensland, should approval be granted by early next year. "We'll roll it out to our customer base in Melbourne firstly, for the fruit shops and food service," he said. Distinguished Professor James Dale is familiar with the approvals process for genetically modified fruit. He leads the Queensland University of Technology's (QUT) Banana Biotechnology Research Program and has been able to get its genetically modified cavendish bananas approved. The banana is resistant to Panama Disease Tropical Race 4, which has threatened commercial production in northern Australia. Professor Dale said getting federal approval was difficult and required proof the fruit was safe for human consumption and the environment. "The application went to hundreds of pages of information because we had to document how we did all of those measurements," he said. The process took about 12 months, but Professor Dale said field trials in the Northern Territory had been completed. More trials will be conducted in north and south-east Queensland over the next three to four months before the crop will be grown commercially. "We're just going to make sure that the banana performs as well over in Queensland, because that's where the vast majority of bananas are grown in Australia," Professor Dale said. The disease-resistant variety is a standard yellow colour, but Professor Dale said the team was working to make bananas healthier and was developing an orange banana high in provitamin A and another high in iron. He said a purple banana with high levels of anthocyanins was also possible. "The purple patches that you see on banana leaves are actually anthocyanins," Professor Dale said.
The Australian
12-06-2025
- The Australian
Study backs Rhythm's colorectal risk model
Rhythm publishes peer-reviewed study validating its next-generation colorectal cancer risk assessment model Proprietary geneType assessment enhanced and cross-validated using data from nearly 400,000 individuals in UK Biobank Next generation geneType design continues focus on usability and simplicity, while providing superior performance Special Report: Rhythm Biosciences has published a peer-reviewed study in PLoS One validating its next-generation colorectal cancer risk assessment model, marking a major step forward in predictive cancer diagnostics. Rhythm Biosciences (ASX:RHY) said the study detailed updates and improvements to its proprietary geneType colorectal cancer risk assessment, which was enhanced and cross-validated using data from nearly 400,000 individuals in the UK Biobank. Rhythm said the article titled 'Colorectal cancer risk prediction using a simple multivariable model' described creation and validation of a new risk model that incorporated sex-specific factors and outperformed current models. The company said as colorectal cancer was a disease associated with many environmental and lifestyle risk factors, the study focused on expanding its geneType model beyond the two primary risk factors – family history and polygenic risk. Watch: Inside ColoSTAT's road to market Key findings of study Rhythm said the study delivered several key findings, most notably development of the enhanced risk model that incorporated three additional risk factors. These factors were selected for their strong associations with colorectal cancer and ease of use in a clinical setting, improving the model's predictive performance over standard family history assessments. The company said the most impactful risk factors were identified and integrated into an updated geneType risk model, which was then tested using data from the UK Biobank. Rhythm said other key findings included: Commitment to improvement – The study highlighted the importance of including clinical and lifestyle factors in multifactorial diseases like colorectal cancer. Commercial application – The new model was designed with commercial clinical applications in mind, minimising the number of risk factors while maximising predictive accuracy. Sex-specific factors – Incorporating sex-specific risk factors enhances model performance across diverse populations. Superior performance – A multivariable risk assessment is shown to be superior to standard of care of family history assessment in its ability to predict risk of developing colorectal cancer. 'Significantly improve stratified screening' Rhythm director of scientific affairs Dr Erika Spaeth said publishing the findings in PLoS One underscored its commitment to advancing cancer risk prediction. 'Our new multifactorial model outperforms previous methods based solely on polygenic risk and family history,' she said. 'By integrating clinical and lifestyle factors, we enhance our prediction accuracy for colorectal cancer. 'We're excited about these results and confident that this model will significantly improve stratified screening in the population." This article was developed in collaboration with Rhythm Biosciences, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
